Skip to content
Medical Health Aged Care

Victorians Gain Access to Cutting-Edge Precision Cancer Therapies Thanks to Landmark $10M Donation

Monash University 3 mins read

Cabrini Health, in partnership with Monash University, is set to transform cancer care for Victorians, thanks to a game-changing $10 million donation. This landmark funding will establish a cutting-edge genomic testing program at Cabrini providing personalised, precision treatment for up to 2,000 additional patients annually.

 

The generous $10 million donation from the PMF Foundation was inspired by the personal experience of a patient under the care of Professor Gary Richardson OAM, Group Director of Cabrini Research and medical oncologist at Cabrini Hospital, who also holds a professorial appointment at Monash University.

 

PMF Foundation Managing Director, Nicola Clyne, said: "The patient personally credited Professor Richardson and the Cabrini team with significantly prolonging their life using genomic profiling throughout their treatment. Their vision was to make a pledge that enables more people with cancer to extend their lives in the same way.”

 

Professor Richardson, leveraging his oncology and genomic research expertise, will lead this transformative initiative at Cabrini. He said: "Through broader, more comprehensive genomic testing panels, our clinicians will be able to precisely identify and target the unique genetic drivers of each patient's cancer - a crucial step in delivering the most effective, tailored care."

 

"Currently, whole genomic testing requests can take up to six months with patient costs up to $4000. Thanks to this generous donation, we aim to reduce this to just weeks by creating the capacity to serve more Victorians in Melbourne's south-east corridor and beyond," adds Professor Richardson.

 

The $10m in funding will be allocated to Cabrini in partnership with Monash over the next five years, establishing the infrastructure to screen over 2,000 additional Victorians genomically per year (1,000 during the first year of operation). The program is expected to begin treating patients in 2025, including public patients who may have previously been unable to afford such specialised testing.

 

The donation will support Cabrini’s appointment of a Monash University affiliated Chair of Genomics and the creation of a dedicated genomics laboratory. This will empower Cabrini Research to expand its precision cancer treatment clinical trials.

 

"If patients enter a system with closer monitoring and access to genomic sequencing, it's proven they do much better," Professor Richardson said. "This donation represents a significant step forward in the fight against cancer."


Professor Richardson is a leading expert in rare cancers which disproportionately contribute to cancer-related deaths. He emphasises that the data generated through this genomic profiling initiative will improve treatments for future generations.

 

For example, the insights gained could unlock a deeper understanding of the complex signalling pathways responsible for triple-negative breast cancer, an aggressive form of the disease that lacks targeted therapies. Similarly, the program will generate data that could lead to targeted therapies for High-Grade Serous Ovarian Carcinoma - a prominent type of ovarian cancer with a low survival rate.

 

- ends –

Notes to editors: About the Cabrini Monash Partnership

Cabrini Health and Monash University’s longstanding partnership provides the opportunity to deliver the most advanced, evidence-based, and patient-centred care. By combining Cabrini's clinical expertise with Monash's academic excellence, the institutions can together potentially unlock transformative breakthroughs that will improve outcomes for patients across Victoria. Cabrini’s partnership with Monash University research is strongly collaborative and strengthened by a ‘bench to bedside' approach.

Thanks to a generous $10 million donation made by a patient in 2024, the two institutions will establish a cutting-edge genomic testing program over the next five years. This program will leverage the latest advancements in genomic medicine to provide personalised, precision treatment, revolutionising the way healthcare is delivered.

 

For media enquiries please contact:

 

Cabrini Health

Lisa Webbe – Communications and Media Manager

media@cabrini.com.au

T: +61 (0) 436 928 801

 

Monash University

Cheryl Critchley – Media and Communications Manager (medical)
E:
cheryl.critchley@monash.edu

T: +61 (0) 477 571 442

More from this category

  • Medical Health Aged Care, Sport Recreation
  • 09/02/2025
  • 11:45
Sports Medicine Australia

Media Call: Concussion campaign aims to to keep kids safe

Sports Medicine Australia is launching a nationwide campaign to help coaches, teachers and sport medicine professionals safely manage the 100,000 sport-related concussions in Australia…

  • Contains:
  • Medical Health Aged Care
  • 09/02/2025
  • 08:41
Royal Australian College of GPs

RACGP applauds Albanese Government’s $573m women’s health package

The Royal Australian College of GPs has applauded the Federal Government’s $573.3 million package for women’s health which includes new funding for menopause health assessments and increased funding for long-acting reversible contraception (LARCs). The Albanese Government package announced today includes more funding for LARC insertion and removal, and to establish LARC training centres. It also includes new funding for menopause health assessments, the development of national guidelines for menopause and perimenopause, and for new generation contraceptive pills to be listed on the Pharmaceutical Benefits Scheme (PBS). RACGP President Dr Michael Wright said: “The RACGP has been calling for more funding…

  • Medical Health Aged Care, Political
  • 09/02/2025
  • 07:34
Monash University

Postcode and income no longer a barrier: improved access to long-acting reversible contraception is a game changer

Today’s federal government announcement of over $570 million to improve women’s health has been welcomed by one of Australia’s foremost experts on women’s reproductive…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.